National randomized controlled trial of virtual house calls for Parkinson disease

被引:154
|
作者
Beck, Christopher A. [1 ]
Beran, Denise B. [2 ]
Biglan, Kevin M. [3 ]
Boyd, Cynthia M. [5 ]
Dorsey, E. Ray [3 ,4 ]
Schmidt, Peter N. [2 ]
Simone, Richard [6 ]
Willis, Allison W. [7 ,8 ]
Galifianakis, Nicholas B. [9 ]
Katz, Maya [9 ]
Tanner, Caroline M. [9 ]
Dodenhoff, Kristen [9 ]
Aldred, Jason [10 ]
Carter, Julie [11 ]
Fraser, Andrew [11 ]
Jimenez-Shahed, Joohi [12 ]
Hunter, Christine [12 ]
Spindler, Meredith [7 ,8 ]
Reichwein, Suzanne [7 ,8 ]
Mari, Zoltan [5 ]
Dunlop, Becky [5 ]
Morgan, John C. [13 ]
McLane, Dedi [13 ]
Hickey, Patrick [14 ]
Gauger, Lisa [14 ]
Richard, Irene Hegeman [3 ]
Mejia, Nicte I. [15 ]
Bwala, Grace [15 ]
Nance, Martha [16 ]
Shih, Ludy C. [17 ]
Singer, Carlos [18 ]
Vargas-Parra, Silvia [18 ]
Zadikoff, Cindy [19 ]
Okon, Natalia [19 ]
Feigin, Andrew [20 ]
Ayan, Jean [20 ]
Vaughan, Christina [21 ]
Pahwa, Rajesh [22 ]
Dhall, Rohit [23 ]
Hassan, Anhar [24 ]
DeMello, Steven [25 ]
Riggare, Sara S. [26 ]
Wicks, Paul [27 ]
Achey, Meredith A. [4 ]
Elson, Molly J. [4 ]
Goldenthal, Steven [4 ]
Keenan, H. Tait [4 ]
Korn, Ryan [4 ]
Schwarz, Heidi [3 ]
Sharma, Saloni [4 ]
机构
[1] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA
[2] Natl Parkinson Fdn, Miami, FL USA
[3] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14627 USA
[4] Univ Rochester, Med Ctr, Ctr Human Expt Therapeut, Rochester, NY 14627 USA
[5] Johns Hopkins Univ, Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD 21205 USA
[6] Simone Consulting, Sunnyvale, CA USA
[7] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[8] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[9] Univ Calif San Francisco, San Francisco, CA 94143 USA
[10] Northwest Neurol PLLC, Spokane, WA USA
[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[12] Baylor Coll Med, Houston, TX 77030 USA
[13] Augusta Univ, Augusta, GA USA
[14] Duke Med Ctr, Durham, NC USA
[15] Massachusetts Gen Hosp, Boston, MA 02114 USA
[16] Struthers Parkinsons Ctr, Minneapolis, MN USA
[17] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[18] Univ Miami, Coral Gables, FL 33124 USA
[19] Northwestern Univ, Evanston, IL USA
[20] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA
[21] Med Univ South Carolina, Charleston, SC USA
[22] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[23] Parkinsons Inst, Sunnyvale, CA USA
[24] Mayo Clin, Rochester, MN USA
[25] Univ Calif Berkeley, CITRIS, Berkeley, CA 94720 USA
[26] Karolinska Inst, Hlth Informat Ctr, Stockholm, Sweden
[27] PatientsLikeMe, Derby, England
关键词
CARE; TELEMEDICINE; ACCESS;
D O I
10.1212/WNL.0000000000004357
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine whether providing remote neurologic care into the homes of people with Parkinson disease (PD) is feasible, beneficial, and valuable. Methods: In a 1-year randomized controlled trial, we compared usual care to usual care supplemented by 4 virtual visits via video conferencing from a remote specialist into patients' homes. Primary outcome measures were feasibility, as measured by the proportion who completed at least one virtual visit and the proportion of virtual visits completed on time; and efficacy, as measured by the change in the Parkinson's Disease Questionnaire-39, a quality of life scale. Secondary outcomes included quality of care, caregiver burden, and time and travel savings. Results: A total of 927 individuals indicated interest, 210 were enrolled, and 195 were randomized. Participants had recently seen a specialist (73%) and were largely college-educated (73%) and white (96%). Ninety-five (98% of the intervention group) completed at least one virtual visit, and 91% of 388 virtual visits were completed. Quality of life did not improve in those receiving virtual house calls (0.3 points worse on a 100-point scale; 95% confidence interval [CI] 22.0 to 2.7 points; p = 0.78) nor did quality of care or caregiver burden. Each virtual house call saved patients a median of 88 minutes (95% CI 70-120; p < 0.0001) and 38 miles per visit (95% CI 36-56; p < 0.0001). Conclusions: Providing remote neurologic care directly into the homes of people with PD was feasible and was neither more nor less efficacious than usual in-person care. Virtual house calls generated great interest and provided substantial convenience. ClinicalTrials.gov identifier: NCT02038959. Classification of evidence: This study provides Class III evidence that for patients with PD, virtual house calls from a neurologist are feasible and do not significantly change quality of life compared to in-person visits. The study is rated Class III because it was not possible to mask patients to visit type.
引用
收藏
页码:1152 / 1161
页数:10
相关论文
共 50 条
  • [21] Patient Education for Patients with Parkinson's Disease - A Randomized Controlled Trial
    Magdalena, Chlond
    Felicitas, Bergmann
    Heike, Schnoor
    Karla, Eggert
    Astrid, Larisch
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2013, 59 (01): : 68 - 69
  • [22] Caffeine as a treatment for Parkinson's disease: A randomized controlled trial (CafePD)
    Postuma, R.
    Anang, J.
    Pelletier, A.
    Moscovich, M.
    Grimes, D.
    Borys, A.
    Furtado, S.
    Munhoz, R.
    Cresswell, S.
    Moro, A.
    Hobson, D.
    Joseph, L.
    Lang, A.
    MOVEMENT DISORDERS, 2017, 32
  • [23] Randomized controlled trial of the Alexander Technique for idiopathic Parkinson's disease
    Stallibrass, C
    Sissons, P
    Chalmers, C
    CLINICAL REHABILITATION, 2002, 16 (07) : 695 - 708
  • [24] Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
    Ramig, Lorraine
    Halpern, Angela
    Spielman, Jennifer
    Fox, Cynthia
    Freeman, Katherine
    MOVEMENT DISORDERS, 2018, 33 (11) : 1777 - 1791
  • [25] A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
    Shoulson, I
    Penney, J
    McDermott, M
    Kieburtz, K
    Schwid, SR
    Kayson, E
    Chase, T
    Fahn, S
    Greenamyre, JT
    Lang, A
    Siderowf, A
    Pearson, N
    Harrison, M
    Rost-Ruffner, E
    Colcher, A
    Lloyd, M
    Matthews, M
    Pahwa, R
    McGuire, D
    Lew, MF
    Schuman, S
    Marek, K
    Broshjeit, S
    Factor, S
    Brown, D
    Feigin, A
    Mazurkiewicz, J
    Ford, B
    Jennings, D
    Dillon, S
    Comella, C
    Blasucci, L
    Janko, K
    Shulman, L
    Wiener, W
    Bateman-Rodriguez, D
    Carrion, A
    Suchowersky, O
    Lafontaine, AL
    Pantella, C
    Siemers, E
    Belden, J
    Davies, R
    Lannon, M
    Grimes, D
    Gray, P
    Martin, W
    Kennedy, L
    Adler, C
    Newman, S
    NEUROLOGY, 2001, 56 (04) : 455 - 462
  • [26] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [27] Improving Prospective Memory in Persons With Parkinson Disease: A Randomized Controlled Trial
    Foster, Erin R.
    McDaniel, Mark A.
    Rendell, Peter G.
    NEUROREHABILITATION AND NEURAL REPAIR, 2017, 31 (05) : 451 - 461
  • [28] Improving functional disability and cognition in Parkinson disease Randomized controlled trial
    Pena, Javier
    Ibarretxe-Bilbao, Naroa
    Garcia-Gorostiaga, Ines
    Angeles Gomez-Beldarrain, Maria
    Diez-Cirarda, Maria
    Ojeda, Natalia
    NEUROLOGY, 2014, 83 (23) : 2167 - 2174
  • [29] Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease
    Leroi, Iracema
    Overshott, Ross
    Byrne, E. Jane
    Daniel, Emily
    Burns, Alistair
    MOVEMENT DISORDERS, 2009, 24 (08) : 1217 - 1221
  • [30] Methylphenidate improves fatigue scores in Parkinson disease:: A randomized controlled trial
    Mendonca, Dan A.
    Menezes, Krishe
    Jog, Mandar S.
    MOVEMENT DISORDERS, 2007, 22 (14) : 2070 - 2076